Seeing Is Believing
Currently out of the existing stock ratings of Jack Wallace, 23 are a BUY (85.19%), 4 are a HOLD (14.81%).
Analyst Jack Wallace, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 40.95% that have a potential upside of 37.12% achieved within 119 days.
Jack Wallace’s has documented 55 price targets and ratings displayed on 7 stocks. The coverage is on Consumer Defensive, Healthcare sectors.
Most recent stock forecast was given on VEEV, Veeva Systems at 01-Oct-2024.
Analyst best performing recommendations are on NXGN (NEXTGEN HEALTHCARE).
The best stock recommendation documented was for NXGN (NEXTGEN HEALTHCARE) at 7/25/2023. The price target of $22 was fulfilled within 43 days with a profit of $5.84 (36.14%) receiving and performance score of 8.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$27
$22.4 (486.96%)
$27
29 days ago
(06-Mar-2025)
0/7 (0%)
$22.4 (486.96%)
Hold
$39
$34.4 (747.83%)
$24
29 days ago
(06-Mar-2025)
1/7 (14.29%)
$34.4 (747.83%)
6
Hold
$40
$35.4 (769.57%)
$40
29 days ago
(06-Mar-2025)
0/3 (0%)
$35.4 (769.57%)
Hold
$35
$30.4 (660.87%)
$35
29 days ago
(06-Mar-2025)
0/2 (0%)
$30.4 (660.87%)
Buy
$68
$63.4 (1378.26%)
$68
29 days ago
(06-Mar-2025)
0/3 (0%)
$63.4 (1378.26%)
What Year was the first public recommendation made by Jack Wallace?